Convergence Investment Partners, LLC Perkinelmer Inc Transaction History

Convergence Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$162.31 - $192.2 $275,115 - $325,779	-1,695 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$166.66 - $201.06 $16,332 - $19,703	-98 Reduced 5.47%	1,695 $341,000
Q3 2021 Oct 25, 2021	SELL	$151.98 - $190.5 $60,184 - $75,438	-396 Reduced 18.09%	1,793 $311,000
Q2 2021 Jul 19, 2021	SELL	$127.81 - $155.84 $25,817 - $31,479	-202 Reduced 8.45%	2,189 $338,000
Q1 2021 Apr 30, 2021	BUY	$120.35 - $160.53 $122,034 - $162,777	1,014 Added 73.64%	2,391 $307,000
Q4 2020 Feb 05, 2021	BUY	$122.05 - $147.91 $168,062 - $203,672	1,377 New	1,377 $198,000
Q2 2018 Aug 07, 2018	SELL	$72.1 - $79.39 $8,724 - $9,606	-121 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$72.06 - $82.75 $8,719 - $10,012	121 New	121 $9,000

574

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.